BIIB Oct 2024 240.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:37PM EDT. Market open.
| Previous close | 13.35 |
| Open | 15.64 |
| Bid | 17.30 |
| Ask | 19.60 |
| Strike | 240.00 |
| Expiry date | 2024-10-18 |
| Day's range | 15.64 - 15.64 |
| Contract range | N/A |
| Volume | |
| Open interest | 13 |
ZacksBiogen (BIIB) Partner Begins Filing for Leqembi SC Autoinjector
Biogen (BIIB) and Eisai start the rolling submission of a biologics license application to the FDA for Leqembi subcutaneous autoinjector as a weekly maintenance dosing regimen for early Alzheimer's disease.
Investor's Business DailyIs Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Eli Lilly stock broke out and then retreated into sell-zone territory. With shares on the rise again, is LLY stock a buy?
Investor's Business DailyBiogen Stock Continues Its 20% Sprint On A Twist In Alzheimer's Treatment
Biogen stock jumped early Wednesday after the FDA gave its Eisai-partnered Alzheimer's treatment a fast track designation.
© 2024 Yahoo. All rights reserved.